US Stock MarketDetailed Quotes

IMMX Immix Biopharma

Watchlist
  • 1.860
  • +0.110+6.29%
Close Nov 8 16:00 ET
  • 1.860
  • 0.0000.00%
Post 20:01 ET
51.06MMarket Cap-2240P/E (TTM)

Immix Biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
26.39%4.7M
121.76%5.59M
96.39%16.14M
41.67%5.38M
195.02%4.52M
138.36%3.72M
89.52%2.52M
507.90%8.22M
534.19%3.79M
340.64%1.53M
Selling and administrative expenses
63.97%2.48M
94.84%2.34M
84.09%7.41M
48.50%2.28M
188.71%2.42M
58.57%1.51M
71.55%1.2M
228.29%4.02M
160.06%1.53M
163.10%837.44K
-General and administrative expense
63.97%2.48M
94.84%2.34M
84.09%7.41M
48.50%2.28M
188.71%2.42M
58.57%1.51M
71.55%1.2M
228.29%4.02M
160.06%1.53M
163.10%837.44K
Research and development costs
0.67%2.22M
146.29%3.25M
108.19%8.74M
37.05%3.1M
202.62%2.11M
263.51%2.21M
109.52%1.32M
3,216.11%4.2M
24,397.17%2.26M
2,244.01%695.94K
Operating profit
-26.39%-4.7M
-121.76%-5.59M
-96.39%-16.14M
-41.67%-5.38M
-195.02%-4.52M
-138.36%-3.72M
-89.52%-2.52M
-507.90%-8.22M
-534.19%-3.79M
-340.64%-1.53M
Net non-operating interest income expense
138.20%306.92K
860.52%267.91K
115,191.75%572.01K
228.58K
186.69K
118,309.17%128.85K
7,288.66%27.89K
99.72%-497
0
0
Non-operating interest income
138.20%306.92K
860.52%267.91K
--572.01K
--228.58K
--186.69K
--128.85K
--27.89K
--0
--0
--0
Non-operating interest expense
----
----
--0
--0
--0
----
----
-99.72%497
--0
--0
Other net income (expense)
Income before tax
-22.38%-4.4M
-113.50%-5.32M
-89.42%-15.57M
-35.65%-5.15M
-182.85%-4.34M
-130.09%-3.59M
-87.37%-2.49M
66.28%-8.22M
83.32%-3.79M
-281.51%-1.53M
Income tax
61.74%10.27K
70.97%8.84K
157.26%26.42K
53.81%8.09K
307.12%6.81K
270.20%6.35K
218.74%5.17K
70.76%10.27K
256.06%5.26K
25.06%1.67K
Net income
-22.45%-4.41M
-113.41%-5.33M
-89.50%-15.6M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
Net income continuous Operations
-22.45%-4.41M
-113.41%-5.33M
-89.50%-15.6M
-35.67%-5.16M
-182.98%-4.34M
-130.24%-3.6M
-87.53%-2.5M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
Minority interest income
41.29%-12.91K
-292.38%-72.07K
-169.47K
-65.86K
-63.25K
-22K
-18.37K
0
0
0
Net income attributable to the parent company
-22.84%-4.39M
-112.08%-5.26M
-87.44%-15.43M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-22.84%-4.39M
-112.08%-5.26M
-87.44%-15.43M
-33.94%-5.09M
-178.86%-4.28M
-128.84%-3.58M
-86.15%-2.48M
66.25%-8.23M
83.30%-3.8M
-280.66%-1.54M
Basic earnings per share
37.50%-0.15
-22.22%-0.22
-50.85%-0.89
11.11%-0.24
-109.09%-0.23
-118.18%-0.24
-80.00%-0.18
91.11%-0.59
84.30%-0.27
-96.40%-0.11
Diluted earnings per share
37.50%-0.15
-22.22%-0.22
-50.85%-0.89
11.11%-0.24
-109.09%-0.23
-118.18%-0.24
-80.00%-0.18
91.11%-0.59
84.30%-0.27
-96.40%-0.11
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 26.39%4.7M121.76%5.59M96.39%16.14M41.67%5.38M195.02%4.52M138.36%3.72M89.52%2.52M507.90%8.22M534.19%3.79M340.64%1.53M
Selling and administrative expenses 63.97%2.48M94.84%2.34M84.09%7.41M48.50%2.28M188.71%2.42M58.57%1.51M71.55%1.2M228.29%4.02M160.06%1.53M163.10%837.44K
-General and administrative expense 63.97%2.48M94.84%2.34M84.09%7.41M48.50%2.28M188.71%2.42M58.57%1.51M71.55%1.2M228.29%4.02M160.06%1.53M163.10%837.44K
Research and development costs 0.67%2.22M146.29%3.25M108.19%8.74M37.05%3.1M202.62%2.11M263.51%2.21M109.52%1.32M3,216.11%4.2M24,397.17%2.26M2,244.01%695.94K
Operating profit -26.39%-4.7M-121.76%-5.59M-96.39%-16.14M-41.67%-5.38M-195.02%-4.52M-138.36%-3.72M-89.52%-2.52M-507.90%-8.22M-534.19%-3.79M-340.64%-1.53M
Net non-operating interest income expense 138.20%306.92K860.52%267.91K115,191.75%572.01K228.58K186.69K118,309.17%128.85K7,288.66%27.89K99.72%-49700
Non-operating interest income 138.20%306.92K860.52%267.91K--572.01K--228.58K--186.69K--128.85K--27.89K--0--0--0
Non-operating interest expense ----------0--0--0---------99.72%497--0--0
Other net income (expense)
Income before tax -22.38%-4.4M-113.50%-5.32M-89.42%-15.57M-35.65%-5.15M-182.85%-4.34M-130.09%-3.59M-87.37%-2.49M66.28%-8.22M83.32%-3.79M-281.51%-1.53M
Income tax 61.74%10.27K70.97%8.84K157.26%26.42K53.81%8.09K307.12%6.81K270.20%6.35K218.74%5.17K70.76%10.27K256.06%5.26K25.06%1.67K
Net income -22.45%-4.41M-113.41%-5.33M-89.50%-15.6M-35.67%-5.16M-182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M
Net income continuous Operations -22.45%-4.41M-113.41%-5.33M-89.50%-15.6M-35.67%-5.16M-182.98%-4.34M-130.24%-3.6M-87.53%-2.5M66.25%-8.23M83.30%-3.8M-280.66%-1.54M
Minority interest income 41.29%-12.91K-292.38%-72.07K-169.47K-65.86K-63.25K-22K-18.37K000
Net income attributable to the parent company -22.84%-4.39M-112.08%-5.26M-87.44%-15.43M-33.94%-5.09M-178.86%-4.28M-128.84%-3.58M-86.15%-2.48M66.25%-8.23M83.30%-3.8M-280.66%-1.54M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -22.84%-4.39M-112.08%-5.26M-87.44%-15.43M-33.94%-5.09M-178.86%-4.28M-128.84%-3.58M-86.15%-2.48M66.25%-8.23M83.30%-3.8M-280.66%-1.54M
Basic earnings per share 37.50%-0.15-22.22%-0.22-50.85%-0.8911.11%-0.24-109.09%-0.23-118.18%-0.24-80.00%-0.1891.11%-0.5984.30%-0.27-96.40%-0.11
Diluted earnings per share 37.50%-0.15-22.22%-0.22-50.85%-0.8911.11%-0.24-109.09%-0.23-118.18%-0.24-80.00%-0.1891.11%-0.5984.30%-0.27-96.40%-0.11
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data